www.neurologiepropraxi.cz / Neurol. praxi. 2024;25(5):357-361 / NEUROLOGIE PRO PRAXI 361 HLAVNÍ TÉMA Kardiovaskulární nežádoucí účinky neurologických a psychiatrických léčiv of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia. BMC Psychiatry. 2011;11:190. doi: 10.1186/1471-244X-11-190. PMID: 22145796; PMCID: PMC3262154. 11. Chai PY, Chang CT, Chen YH, Chen HY, Tam KW. Effect of drug interactions between carbapenems and valproate on serum valproate concentration: a systematic review and meta‑analysis. Expert Opin Drug Saf. 2021;20(2):215-223. doi: 10.1080/14740338.2021.1865307. Epub 2020 Dec 28. PMID: 33322967. 12. Isbister GK, Page CB. Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. Br J Clin Pharmacol. 2013;76(1):48-57. doi: 10.1111/ bcp.12040. PMID: 23167578; PMCID: PMC3703227. 13. Jia L, Eroglu TE, Wilders R, et al. Carbamazepine Increases the Risk of Sudden Cardiac Arrest by a Reduction of the Cardiac Sodium Current. Front Cell Dev Biol. 2022;10:891996. doi: 10.3389/fcell.2022.891996. PMID: 35721495; PMCID: PMC9204209. 14. Lima B, Razmjouei S, Bajwa MT, et al. Polypharmacy, Gender Disparities, and Ethnic and Racial Predispositions in Long QT Syndrome: An In‑Depth Review. Cureus. 2023;15(9):e46009. doi: 10.7759/cureus.46009. PMID: 37900391; PMCID: PMC10600617. 15. Manolis TA, Manolis AA, Manolis AS. Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale. Angiology. 2019;70(2):103-129. doi: 10.1177/0003319718780145. Epub 2018 Jun 6. PMID: 29874922. 16. Rommer PS, Zettl UK. Managing the side effects of multiple sclerosis therapy: pharmacotherapy options for patients. Expert Opin Pharmacother. 2018;19(5):483-498. doi: 10.1080/14656566.2018.1446944. Epub 2018 Mar 12. PMID: 29528247. 17. Shao W, Ayub S, Drutel R, et al. QTc Prolongation Associated With Psychiatric Medications: A Retrospective Cross ‑Sectional Study of Adult Inpatients. J Clin Psychopharmacol. 2019;39(1):72-77. doi: 10.1097/JCP.0000000000000992. PMID: 30531476. 18. Sicouri S, Antzelevitch C. Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest. Arrhythm Electrophysiol Rev. 2018;7(3):199-209. doi: 10.15420/aer.2018. 29. 2. PMID: 30416734; PMCID: PMC6141916. 19. Spoelhof B, Farrokh S, Rivera‑Lara L. Drug Interactions in Neurocritical Care. Neurocrit Care. 2017;27(2):287-296. doi: 10.1007/s12028-016-0369-0. PMID: 28054285. 20. Stillman MJ, Tepper S, Tepper DE, et al. QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 1: review of serotonergic cardiac adverse events with a triptan case. Headache. 2013;53(1):208-216. doi: 10.1111/j.1526-4610.2012.02300.x. Epub 2012 Dec 6. Erratum in: Headache. 2013 Mar;53(3):57980. PMID: 23216317. 21. Stillman MJ, Tepper DE, Tepper SJ, et al. QT prolongation, Torsade de Pointes, myocardial ischemia from coronary vasospasm, and headache medications. Part 2: review of headache medications, drug‑drug interactions, QTc prolongation, and other arrhythmias. Headache. 2013;53(1):217224. doi: 10.1111/j.1526-4610.2012.02299.x. Epub 2012 Dec 6. PMID: 23216298. 22. Yadav R, Schrem E, Yadav V, et al. Lacosamide‑Related Arrhythmias: A Systematic Analysis and Review of the Literature. Cureus. 2021;13(12):e20736. doi: 10.7759/cureus.20736. PMID: 35111429; PMCID: PMC8790938. 23. Vazquez SR. Drug‑drug interactions in an era of multiple anticoagulants: a focus on clinically relevant drug interactions. Blood. 2018;132(21):2230-2239. doi: 10.1182/blood-2018-06-848747. PMID: 30463993. 24. Wang J, Huang P, Yu Q, et al. Epilepsy and long‑term risk of arrhythmias. Eur Heart J. 2023;44(35):3374-3382. doi: 10.1093/eurheartj/ehad523. PMID: 37602368; PMCID: PMC10499547. 25. Zaccara G, Perucca E. Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord. 2014;16(4):409-31. doi: 10.1684/epd.2014.0714. PMID: 25515681. 26. Zhou JY, Martinez JA, Shen JP. Lamotrigine‑induced hemophagocytic lymphohistiocytosis with Takotsubo cardiomyopathy: a case report. J Med Case Rep. 2019;13(1):345. doi: 10.1186/s13256-019-2295-1. PMID: 31767022; PMCID: PMC6878683. ODBORNÝ GARANT: doc. RNDr. MUDr. Pavel Ješina, Ph.D. POŘADATEL: Společnost SOLEN, s. r. o., ve spolupráci s Klinikou pediatrie a dědičných poruch metabolismu 1. LF UK a VFN v Praze ZLATÝ PARTNER POČET KREDITŮ 2 Registrace ZDARMA TERMÍN květen 2024 až duben 2025 dostupný na online.solen.cz ON LINE KURZ OBSAH KURZU Úvod do lyzosomálních střádavých onemocnění doc. RNDr. MUDr. Pavel Ješina, Ph.D. Niemann-Pickova choroba typu B – nové léčitelné onemocnění doc. RNDr. MUDr. Pavel Ješina, Ph.D. Gaucherova nemoc – snadno diagnostikovatelné onemocnění MUDr. Stella Reichmannová, Ph.D. Pompeho nemoc – jak odhalit typické i méně typické případy MUDr. Lívie Mensová Diskuze Našli jsme vzácného pacienta – hledejme dál
RkJQdWJsaXNoZXIy NDA4Mjc=